An automated modular assembly line for drugs in a miniaturized plant
Category
Published on
Abstract
We report here a fully automated, end-to-end, integrated continuous manufacturing process for a small-molecule generic medication with built-in quality assurance. The entire process fits into a box of 30.7 m2 modular footprint and a total residence time of less than 30 h, with a throughput up to 40.3 x10-6 tablets per year
Journal
Chemical Communications. Volume 7, 2020
DOI
10.1039/c9cc06945c
Type of publication
Peer-reviewed journal
Affiliations
- Continuus Pharmaceuticals
- IMA S.p.A.
- Food and Drug Administration (FDA)USV Private Limited
Article Classification
Other
Classification Areas
- PAT
- Oral solid dose